Characteristics of Successful International Pharmacy Partnerships (original) (raw)
Related papers
International Journal of Business Administration
To overcome internal and external obstacles, including political crises, the Iranian pharmaceutical industry forms strategic collaborations. The high failure rate of strategic partnerships emphasizes the need to identify and evaluate success factors at different stages of the alliance lifecycle. Additionally, directed content analysis is used to assess the findings. In the formation phase, the most critical factors are partner selection and choice of the most important governance form, whereas in the operation phase, relational capital, coordination, conflict management, and selecting the appropriate alliance people are crucial. Evaluation of alliance performance should be undertaken throughout the duration of the alliance's existence.
Pharmaceutical products play an important role in the human life and improvement of patients. There are many types of medicine for which the supply chain networks have been spread around the world. This extensive application and communication in the logistic of pharmaceutical products entail efficient management and coordination of involved partners. Also, many organizations including private and public organizations as well as financial and insurance companies implement the functions of pharmaceutical services in health systems. Effective management of the partners’ relationships in a coordinated and integrated manner requires cooperative strategies. Furthermore, the evaluation of these strategies requires consideration of different aspects of cooperation, the participatory capabilities of partners, and necessary incentives facilitating their participation. In this thesis, the establishment of a strategic alliance, between producers of the new and patented pharmaceutical products b...
Strengthening Pharmacy, Globally. Looking Outside the Box
Innovations in pharmacy, 2017
To strengthen pharmacy practice globally, new and more efficient strategies are needed. Pharmacy has traditionally viewed medicine as its reference group. This commentary questions the appropriateness of medicine as a benchmark for pharmacy and suggests the need for new thinking on the professionalization of pharmacy. Useful lessons from outside the medical field, in matters of professional training, practice and autonomy, are highlighted. The commentary concludes that, strategies that focus on the consumer are more effective in transforming practice globally. Type: Commentary
Barriers to Internationalization – a Study of the Pharmacy Sector in Trinidad and Tobago
International Journal of Science Innovations and Discoveries
This study seeks to examine the barriers to internationalization faced by the retail pharmacy sector in Trinidad and Tobago. The study used a survey methodology designed to measure a firm’s willingness to internationalize and to determine the barriers that pharmacies perceive as being major constraints in their efforts at moving beyond the borders of Trinidad and Tobago. Three hypotheses were put forward and tested. Of them, Hypothesis 1, which stated that finance was a major constraint, and Hypothesis 2, which stated that network connections were perceived as critical for internationalization were proven to be true. Hypothesis 3, that younger firms are more willing to internationalize, did not prove to be significant. The results show that while finance and networks are major barriers, age of the firms is not significant.
Interprofessional collaborative care has been shown to improve patient outcomes. Physicians' views on collaboration with pharmacists give an insight into what contributes to a well-functioning team. Little is known about these views from low and middle-income countries and nothing from the United Arab Emirates (UAE). The purpose of this study is to investigate physicians' opinions on collaborative relationships with community pharmacists in the UAE. Semi-structured individual interviews and group discussions are conducted with a purposive sample of physicians. Thematic analysis based on the framework approach is used to generate themes. A total of 53 physicians participated. Three themes about collaboration emerged: perceived benefits of collaboration, facilitators of collaboration and perceived barriers to collaboration. Perceived benefits include reducing the burden on physicians, having the pharmacist as an extra safety check within the system, having the pharmacist assist patients to manage their medications: coping with side effects, reducing drug waste and costs, and attaining professional and health-system gains. Perceived facilitators included awareness and trust building, professional role definition, pharmacists' access to patient records and effective communication. Perceived barriers included patient and physician acceptance, logistic and financial issues and perceived pharmacist competence. This study has, for the first time, provided useful information to inform the future development of pharmacist-physician collaboration in the UAE and other countries with similar healthcare systems.
Journal of International Business Studies, 2009
Alliances are recognized as an indispensable tool for managers operating in a global business environment, and as a fundamental stage of the internationalization process of the firm. Drawing on a co-evolutionary framework, this article investigates the mimetic and experiential effects in international alliance formation. We focus on a critical unresolved issue in the literature: what is the role of mimetic behavior and previous alliance experience in mitigating the uncertainty associated with engaging in cross-border operations? An event history analysis of 792 international marketing alliance formations initiated by 317 firms in the US pharmaceutical industry is employed to test the hypotheses. The findings of two different hazard rate models reveal significant complex effects of density and cross-border alliance experience on the propensity to engage in new international marketing alliances.
Internal Medicine Journal, 2005
AbstractBackground: There is extensive and varied interaction between the pharmaceutical industry and the medical profession. Most empirical research concerns contact between individual physicians and industry, and reflects North American experience. We sought to clarify the extent and nature of relationships between the pharmaceutical industry and Australian medical organizations.Methods: We administered questionnaires to 63 medical organizations concerned with clinical practice, continuing medical education or professional accreditation, or the political representation of medical professionals.Results: Survey instruments were received from 29 organizations, giving a response rate of 46%. Seventeen of these organizations (59%) had received support from one or more pharmaceutical company in the past financial year. Support was predominantly for annual conferences, with some support for continuing medical education, research, travel and library purchases. The majority of organizations had an academic journal or newsletter, and 10 (34%) accepted revenue from pharmaceutical advertising. Twenty organizations (72%) had policies or guidelines covering their relationship with industry. Few organizations indicated that they would be unable to continue their activities without pharmaceutical industry support.Conclusion: These data indicate a high level of interaction between the pharmaceutical industry and medical organizations in Australia. While most organizations have policies for guiding their relationship with industry, it is unclear whether these are effective in preventing conflicts of interest and maintaining public trust. (Intern Med J 2005; 35: 206–210)